{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:49:48Z","timestamp":1770331788047,"version":"3.49.0"},"reference-count":33,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Brain tumors, whether primary gliomas or metastases from breast, lung, melanoma, or other systemic malignancies, share a unique biological feature: the ability to infiltrate brain parenchyma and adapt to the unique microenvironment of the central nervous system [...]<\/jats:p>","DOI":"10.3390\/ijms27031555","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:35:37Z","timestamp":1770287737000},"page":"1555","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Special Issue \u201cInvasion and Metastasis in Brain Cancer\u201d"],"prefix":"10.3390","volume":"27","author":[{"given":"Aleksandra","family":"Glogowska","sequence":"first","affiliation":[{"name":"Department of Human Anatomy and Cell Science, Faculty of Health Science, College of Medicine, University of Manitoba, Winnipeg, MB R3E 0T4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5948-508X","authenticated-orcid":false,"given":"Saeid","family":"Ghavami","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy and Cell Science, Faculty of Health Science, College of Medicine, University of Manitoba, Winnipeg, MB R3E 0T4, Canada"},{"name":"Paul Albrechtsen Research Institute Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada"},{"name":"Children Hospital Research Institute of Manitoba, Winnipeg, MB R3E 0Z3, Canada"},{"name":"Faculty of Medicine, Akademia \u015al\u0105ska, Rolna 43, 40-555 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s43556-025-00251-0","article-title":"Cancer Brain Metastasis: Molecular Mechanisms and Therapeutic Strategies","volume":"6","author":"Lu","year":"2025","journal-title":"Mol. Biomed."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","article-title":"Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells","volume":"181","author":"Klemm","year":"2020","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Jacome, M.A., Wu, Q., Chen, J., Sidi Mohamed, Z., Mokhtari, S., Pi\u00f1a, Y., and Etame, A.B. (2025). Molecular Underpinnings of Brain Metastases. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26052307"},{"key":"ref_5","first-page":"53","article-title":"Mechanisms of invasion in glioblastoma: Extracellular matrix, Ca2+ signaling, and glutamate","volume":"9","author":"So","year":"2021","journal-title":"Brain Tumor Res. Treat."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Erices, J.I., Bizama, C., Niechi, I., Uribe, D., Rosales, A., Fabres, K., Navarro-Mart\u00ednez, G., Torres, \u00c1., San Mart\u00edn, R., and Roa, J.C. (2023). Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087047"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Seker-Polat, F., Pinarbasi Degirmenci, N., Solaroglu, I., and Bagci-Onder, T. (2021). Tumor cell infiltration into the brain in glioblastoma: Mechanisms and clinical perspectives. Cancers, 14.","DOI":"10.3390\/cancers14020443"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s10143-024-02944-6","article-title":"Glioblastoma invasion patterns from a clinical perspective\u2014A systematic review","volume":"47","author":"Percuoco","year":"2024","journal-title":"Neurosurg. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Oishi, T., Koizumi, S., and Kurozumi, K. (2022). Molecular Mechanisms and Clinical Challenges of Glioma Invasion. Brain Sci., 12.","DOI":"10.3390\/brainsci12020291"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1038\/s41467-025-61999-1","article-title":"The Invasion Phenotypes of Glioblastoma Depend on Plastic and Reprogrammable Cell States","volume":"16","author":"Doroszko","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Campbell, B.K., Gao, Z., Corcoran, N.M., Stylli, S.S., and Hovens, C.M. (2022). Molecular Mechanisms Driving the Formation of Brain Metastases. Cancers, 14.","DOI":"10.3390\/cancers14194963"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"115090","DOI":"10.1016\/j.bcp.2022.115090","article-title":"Gliomas: Genetic alterations, mechanisms of metastasis, recurrence, drug resistance, and recent trends in molecular therapeutic options","volume":"201","author":"Kannan","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Rep."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Tripathy, D.K., Panda, L.P., Biswal, S., and Barhwal, K. (2024). Insights into the glioblastoma tumor microenvironment: Current and emerging therapeutic approaches. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1355242"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: An overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature12627","article-title":"Tumour heterogeneity in the clinic","volume":"501","author":"Bedard","year":"2013","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Trevisi, G., and Mangiola, A. (2023). Current Knowledge about the Peritumoral Microenvironment in Glioblastoma. Cancers, 15.","DOI":"10.3390\/cancers15225460"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e12345","DOI":"10.1016\/j.heliyon.2024.e41309","article-title":"Metabolomic characterisation of the glioblastoma invasive margin reveals a region-specific signature","volume":"11","author":"Wood","year":"2025","journal-title":"Heliyon"},{"key":"ref_21","first-page":"345","article-title":"Investigation of metabolic features of glioblastoma tissue and the peritumoral environment using targeted metabolomics screening by LC MS\/MS and gene network analysis","volume":"28","author":"Basov","year":"2024","journal-title":"Vavilovskii Zhurnal Genet. Sel."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/brainsci11020200","article-title":"Peritumoral microenvironment in high grade gliomas: miRNA patterns and cross talk between GBM and microenvironment","volume":"11","author":"Altieri","year":"2021","journal-title":"Brain Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13059-024-03407-3","article-title":"Spatiotemporal Modeling Reveals High-Resolution Invasion States in Glioblastoma","volume":"25","author":"Abdelkareem","year":"2024","journal-title":"Genome Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2017.01.004","article-title":"The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment","volume":"451","author":"Chang","year":"2017","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjc.6603886","article-title":"p53 and Its Isoforms in Cancer","volume":"97","author":"Bourdon","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_28","first-page":"1893","article-title":"PI3K\/AKT\/Afadin Signaling Pathway Contributes to Pathological Vascularization in Glioblastomas","volume":"15","author":"Zhai","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Peleli, M., Moustakas, A., and Papapetropoulos, A. (2020). Endothelial\u2013Tumor Cell Interaction in Brain and CNS Malignancies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197371"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3892\/ol.2016.4171","article-title":"High expression of UBE2C is associated with the aggressive progression and poor outcome of malignant glioma","volume":"11","author":"Ma","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_31","first-page":"182","article-title":"Ubiquitin-conjugating enzyme E2C: A potential cancer biomarker","volume":"54","author":"Xie","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s40364-025-00854-3","article-title":"Decoding the Mechanisms Underlying Breast Cancer Brain Metastasis: Paving the Way for Precision Therapeutics","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomark. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1158\/1078-0432.CCR-10-1564","article-title":"Heterogeneous Blood\u2013Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer","volume":"16","author":"Lockman","year":"2010","journal-title":"Clin. Cancer Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/3\/1555\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:37:19Z","timestamp":1770287839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/3\/1555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["ijms27031555"],"URL":"https:\/\/doi.org\/10.3390\/ijms27031555","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]}}}